GP-Act III Acquisition (GPAT) Shares Outstanding (Weighted Average) (2023 - 2025)

GP-Act III Acquisition has disclosed Shares Outstanding (Weighted Average) across 3 years of filings, most recently posting $28.8 million for Q4 2025.

• Quarterly Shares Outstanding (Weighted Average) rose 34.5% year-over-year to $28.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $28.8 million (up 34.5% YoY) and the FY2025 annual result came in at $28.8 million, up 34.5% from the prior year.
• Shares Outstanding (Weighted Average) improved to $28.8 million in Q4 2025, from $7.2 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $28.8 million in Q3 2024 and troughed at $6.2 million in Q1 2023.
• A 3-year average of $13.3 million and a median of $6.8 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• Annual changes were most pronounced in 2024 — Shares Outstanding (Weighted Average) surged 360.0% — and 2025, when it sank 75.0%.
• Tracing GPAT's Shares Outstanding (Weighted Average) over 3 years: stood at $6.2 million in 2023, then soared by 242.0% to $21.4 million in 2024, then soared by 34.5% to $28.8 million in 2025.
• Business Quant data shows GPAT's Shares Outstanding (Weighted Average) at $28.8 million in Q4 2025, $7.2 million in Q3 2025, and $7.2 million in Q2 2025.